Achyut Healthcare Ltd
BSE:543499
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
TTK Healthcare Ltd
BSE:507747
|
IN |
|
R
|
Remedy Entertainment Oyj
OMXH:REMEDY
|
FI |
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| IN |
A
|
Achyut Healthcare Ltd
BSE:543499
|
1.3B INR |
Loading...
|
|
| US |
|
Mckesson Corp
NYSE:MCK
|
106.3B USD |
Loading...
|
|
| US |
|
Cencora Inc
NYSE:COR
|
62.1B USD |
Loading...
|
|
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
61.6B USD |
Loading...
|
|
| US |
|
Cardinal Health Inc
NYSE:CAH
|
50.5B USD |
Loading...
|
|
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
30.7B AUD |
Loading...
|
|
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
63.3B CNY |
Loading...
|
|
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
61.3B CNY |
Loading...
|
|
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.8B USD |
Loading...
|
|
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW |
Loading...
|
|
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
63.4B HKD |
Loading...
|
Market Distribution
| Min | -3 052.3% |
| 30th Percentile | 26.9% |
| Median | 39% |
| 70th Percentile | 53.3% |
| Max | 8 269.1% |
Other Profitability Ratios
Achyut Healthcare Ltd
Glance View
Achyut Healthcare Ltd. engages in the trading of pharmaceutical products. The company is headquartered in Ahmedabad, Gujarat. The company went IPO on 2022-03-30. The firm operates in the single business segment of manufacturing pharmaceutical formulations in the forms of tablets, capsules, oral liquids, and injectables. The company is focused on dealing in active pharmaceutical ingredients (API), pharmaceutical products, and medical devices. The firm is engaged in the trading of Cenzure, Arpimune, Azathioprine IP, Everomimus, Mycophenolate Mofetil USP, Mycophenolate Sodium USP, Sirolimus, Tacrolimus USP, Infrared thermometer, Ascorbic Acid Coated Vitamin C, Calcium Carbonate Oyster, Cellulose Acetate Phthalate, Chlorthalidone IP, Cross Carmalose Sod IP/USP, DI Basic Calcium Phosphate IP, DI Ethyl Phthlate, among many other products. The firm is in the trading business in both domestic as well as international markets in the countries of the United Arab Emirates (UAE), Kenya, and Nigeria.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Achyut Healthcare Ltd is 5.8%, which is below its 3-year median of 6.6%.
Over the last 1 years, Achyut Healthcare Ltd’s Gross Margin has decreased from 9.9% to 5.8%. During this period, it reached a low of 4.2% on Sep 30, 2024 and a high of 9.9% on Mar 2, 2024.
